Three Of The Biggest Catastrophes In ADHD Medication Pregnancy The ADHD Medication Pregnancy's 3 Biggest Disasters In History > 자유게시판

ADHD Medication During Pregnancy and Breastfeeding

Women suffering from ADHD have to make a difficult choice about whether to continue or stop taking ADHD medication during pregnancy and breast-feeding. There isn't much information on how long-term exposure to these drugs may affect the foetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication in utero do not develop neurological developmental disorders like hearing loss or impaired vision, febrile seizures, or IQ impairment. The authors acknowledge that more high quality research is needed.

Risk/Benefit Analysis

Women who are expecting and taking ADHD medication should evaluate the benefits of using it against the potential risks to the fetus. Doctors don't have the data needed to give clear guidelines, but they can provide information regarding risks and benefits that help pregnant women make informed decisions.

A study published in Molecular Psychiatry concluded that women who were taking ADHD medication in early pregnancy did not have a greater risk of fetal malformations or structural birth defects. Researchers used a large population-based study of case control to compare the incidence of structural defects that were major in infants born to mothers who took stimulants during pregnancy. Pediatric cardiologists and clinical geneticists looked over the cases to ensure accurate classification of the cases and to reduce the possibility of bias.

The research conducted by the researchers was not without limitations. Most important, they were unable to separate the effects of the medication from the disorder at hand. This makes it difficult to determine whether the small differences observed in the exposed groups result from medication use or the confounding effect of comorbidities. Additionally the researchers did not study long-term offspring outcomes.

The study showed that infants whose mother took ADHD medication during pregnancy had a slightly higher chance of being admitted to the neonatal care unit (NICU), compared to mothers who did not take any medication during pregnancy or stopped taking their medication before or during pregnancy. The reason for this was central nervous system disorders, and the increased risk of admission did not appear to be influenced by which stimulant medication was used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher likelihood of having to have caesarean sections or a baby that scored low on the Apgar scale (less than 7). These increases did appear to be independent of the type of medication taken during pregnancy.

Researchers suggest that the small risk of using adhd medication without diagnosis uk medications during early pregnancies could be offset by the more beneficial outcomes for both mother and baby of continuing treatment for the woman's condition. Physicians should discuss this with their patients and, where they are able, assist them in developing strategies to improve coping skills that may minimize the impact of her disorder on her daily functioning and relationships.

Medication Interactions

More and more doctors are confronted with the dilemma of whether to continue treatment or stop during pregnancy as more women are diagnosed with ADHD. These decisions are usually made without clear and authoritative evidence. Instead, doctors have to take into account their own experience, the experience of other doctors, and the research on the subject.

Particularly, the issue of possible risks to the baby can be a challenge. The research on this issue is based on observation rather than controlled studies and many of the findings are conflicting. Additionally, the majority of studies limit their analysis to live births, which can underestimate severe teratogenic effects that cause abortion or termination of the pregnancy. The study discussed in the journal club addresses these limitations, by examining both the data from deceased and live births.

Conclusion A few studies have revealed an association between ADHD medications and certain birth defects, other studies have not found a correlation. The majority of studies show a neutral, or even somewhat negative, effect. In every case it is imperative to conduct a thorough study of the risks and benefits is required.

It isn't easy, but not impossible, for women suffering from ADHD to stop taking their medication. In a recent article published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can increase depression and feelings of loneliness. Additionally, the loss of medication may affect the ability to perform work-related tasks and safely drive which are essential aspects of a normal life for many people suffering from ADHD.

She suggests that women who are not sure whether to take the medication or discontinue it due to pregnancy educate family members, coworkers, and their friends about the condition, its effects on daily functioning, and the benefits of continuing the current treatment plan. It will also help a woman feel more confident in her decision. Certain medications can be passed through the placenta. If a woman decides to stop taking her ADHD medication while breastfeeding, it's important to be aware that the medication may be transferred to her baby.

Risk of Birth Defects

As the use of Adhd medication names List drugs to treat symptoms of attention deficit hyperactivity disorder (best adhd medication for adults with anxiety and depression) grows there are concerns over the impact that these drugs might have on the fetuses. A recent study published in the journal Molecular Psychiatry adds to the existing knowledge about this subject. Researchers used two huge data sets to examine over 4.3 million pregnant women and determine whether stimulant medications increased the risk of birth defects. Researchers found that while the overall risk is low, first-trimester ADHD medication use was associated with slightly higher risk of specific heart defects such as ventriculoseptal defect.

The authors of the study could not find any association between early use of medication and other congenital anomalies such as facial deformities or club feet. The results are in agreement with previous studies which showed an insignificant, but small increase in cardiac malformations for women who started taking ADHD medication prior to the time of pregnancy. This risk increased during the latter stages of pregnancy when a large number of women began to stop taking their medication.

Women who were taking ADHD medication in the first trimester were more likely require a caesarean birth or have an insufficient Apgar after delivery and have a baby who needed breathing assistance after birth. The researchers of the study were unable to eliminate selection bias because they limited the study to women who did not have any other medical conditions that could have contributed to the findings.

Researchers hope their research will help doctors when they meet pregnant women. They recommend that, while discussing risks and benefits is important, the decision to stop or maintain medication must be based on each woman's needs and the severity of her ADHD symptoms.

The authors caution that, even though stopping the medication is a possibility to look into, it is not advised due to the high rate depression and other mental disorders in women who are expecting or have recently given birth. Further, research shows that women who stop taking their medication will have a tough adjustment to life without them after the baby is born.

Nursing

The responsibilities of a new mom can be overwhelming. Women with ADHD may face a lot of challenges when they must deal with their symptoms, attend doctor appointments, prepare for the birth of a child and adjust to a new routine. Therefore, many women decide to continue taking their ADHD medications throughout pregnancy.

The majority of stimulant medicines are absorbed through breast milk in small amounts, so the risk to breastfeeding infant is minimal. However, the frequency of medication exposure to the newborn may differ based on dosage, how often it is administered, and the time of the day the medication is administered. In addition, different medications enter the baby’s system via the gastrointestinal tract, or through breast milk. The effect on a newborn's health is not completely known.

Some physicians may discontinue stimulant medication during a woman’s pregnancy due to the lack of research. This is a complicated decision for the patient, who must weigh the benefits of keeping her medication against the potential dangers to the fetus. As long as more information is available, GPs can my general practitioner prescribe adhd medication ask pregnant patients if they have a history of ADHD or if they plan to take medication during the perinatal period.

A increasing number of studies have shown that women can continue taking their ADHD medication while they are pregnant and nursing. This has led to more and more patients opt to do this, and in consultation with their physician, they have discovered that the benefits of maintaining their current medication far exceed any risk.

Women with ADHD who are planning to nurse should seek advice from an expert psychiatrist prior to becoming pregnant. They should review their medications with their doctor and discuss the advantages and disadvantages of continuing treatment, including non-pharmacological strategies. Psychoeducation is also needed to help pregnant women suffering from ADHD recognize the signs and the underlying disorder. They should also learn about treatment options and build the coping mechanisms. This should be an approach that is multidisciplinary, including the GP as well as obstetricians, psychiatry and obstetricians. Pregnancy counseling should include discussion of a treatment plan for the mother and child, as well as monitoring for indicators of deterioration, and, if needed, adjustments to the medication regimen.